NCT07187869 2025-09-23Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept StudyM.D. Anderson Cancer CenterPhase 1 Not yet recruiting16 enrolled